News-Papers
Testimonial
Video Gallery
 | |||||
 |  |  |  |  |  |
Search
Follow us...
Latest
- Melatonin: an endogenous miraculous indolamine, fights against cancer progression
- Melatonin and breast cancer: Evidences from preclinical and human studies
- Melatonin induces autophagy in neuroblastoma by alleviating Pak2‑mediated endoplasmic reticulum stress
- In vivo dynamic monitoring of self-assembled melatonin nanodrug combined with photothermal effects to alleviate hypoxia to attenuate tumor aggressiveness
- Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
- Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
- Plasma melatonin and the hormone-dependency of human breast cancer
- Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
- Melatonin: A Molecule for Reducing Breast Cancer Risk
- Melatonin: an inhibitor of breast cancer
- Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
- The Intricate Relationship between Melatonin and Breast Cancer: A Short Review
- Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis
- Vitamin D supplementation to the older adult population in Germany has the cost-saving potential of preventing almost 30,000 cancer deaths per year
- Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
- Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process
- The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment
- Melatonin's protective effect on the salivary gland against ionized radiation damage in rats
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer